Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1984 1
1998 1
2006 1
2011 1
2012 1
2015 1
2016 1
2017 1
2020 2
2021 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience.
Berinstein JA, Karl T, Patel A, Dolinger M, Barrett TA, Ahmed W, Click B, Steiner CA, Dulaney D, Levine J, Hassan SA, Perry C, Flomenhoft D, Ungaro RC, Berinstein EM, Sheehan J, Cohen-Mekelburg S, Regal RE, Stidham RW, Bishu S, Colombel JF, Higgins PDR. Berinstein JA, et al. Among authors: flomenhoft d. Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002674. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38275248
Ustekinumab dose escalation improves clinical responses in refractory Crohn's disease.
Haider SA, Yadav A, Perry C, Su L, Akanbi O, Kudaravalli P, Tripathi N, Hashim MA, Abdelsalam M, Hussein M, Elkheshen A, Patel V, Ali SE, Lamb L, Ingram K, Mayne C, Stuffelbeam AB, Flomenhoft D, Stromberg A, Barrett TA. Haider SA, et al. Among authors: flomenhoft d. Therap Adv Gastroenterol. 2020 Oct 13;13:1756284820959245. doi: 10.1177/1756284820959245. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 33133239 Free PMC article.
Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's Disease.
Pauly NJ, Michailidis L, Kindred MG, Flomenhoft D, Lofwall MR, Walsh SL, Talbert JC, Barrett TA. Pauly NJ, et al. Among authors: flomenhoft d. Inflamm Bowel Dis. 2017 Jun;23(6):1004-1010. doi: 10.1097/MIB.0000000000001087. Inflamm Bowel Dis. 2017. PMID: 28368908 Free PMC article.
15 results